2024 Conference Coverage


 

Multi-Institutional Study of Neurologic Outcomes in People With Multiple Sclerosis Who Are Treated With Immune Checkpoint Inhibitors (ICIs) for Oncologic Indications

0 views
May 8, 2024
Comments 1
Login to view comments. Click here to Login